Couling John D sold $460K of DLB

Couling John D (SVP, Entertainment) sold 7,667 shares of Dolby Laboratories, Inc. (DLB) at an average of $60.00 ($59.03–$60.11, $0.46M total) across 2 trades on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Couling John D
Published Aug 5, 2026, 9:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 9:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$DLB
Neutral
high confidence
Mentioned
$DLB
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DLBNeutralLow
01

Why it matters

The only new information is the disclosed sale size, execution dates, average prices, and post-transaction share count; it does not include any new company performance or outlook details.

02

Market read

Traders may note the insider sale for sentiment monitoring, but it is unlikely to drive a fundamental repricing absent additional catalysts.

03

What to watch

The filing does not state whether other insiders or the company also made concurrent purchases, nor does it provide context on compensation timing or tax-related selling beyond the 10b5-1 designation.

Relevance 3/10Novelty 3/10Timing: Filed 2026-08-05, covering sales executed 2026-08-03.

Background

The article is a SEC Form 4 insider transaction disclosure for Dolby Laboratories, Inc. (DLB) by Couling John D, SVP, Entertainment.

Company-level read

Ticker impact

$DLBNeutralHigh confidence
Context

Dolby Laboratories SVP sold $460,003.89 of DLB shares via a 10b5-1 plan on 2026-08-03, disclosing post-sale holdings of 118,727 shares.

Expected impact

Likely limited near-term price impact; any effect would be modest and short-lived unless paired with other company-specific news.

Evidence & confidence

The filing is a Form 4 insider transaction with explicit 10b5-1 pre-arrangement, and it does not include new operational, financial, or regulatory information.

Market effects

No clear sector read-through because the disclosure is an individual insider sale without accompanying company guidance or product/regulatory updates.

None indicated; this is a US-listed issuer insider transaction.

None indicated; no cross-border deal, regulation, or supply-chain event is described.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations, so the market should not over-interpret it.

Key entities

  • Dolby Laboratories, Inc.

    US-listed company whose shares were sold by an insider under a 10b5-1 plan.

  • Couling John D

    SVP, Entertainment who executed open-market sales totaling $460,003.89.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVDAMedAI 8/10

Futures Rise As Huang-less Nvidia Beats And Raises, Gold Crashes Below $3,800

US futures rise as Nvidia (NVDA) reports strong earnings and raises guidance, boosting AI-related stocks. Gold drops below $3,800 after Fed Governor Waller's comments. Nvidia's Q4 revenue guidance is $130B vs. estimates of $125B. Premarket movers include TSLA, GOOGL, AMZN, AAPL, META, AVGO, CRWV, AAOI, BLSH, DLB, LOW, SLS, TTWO, TNDM. Fed policy and economic data releases are in focus.

$DLBMed

Dolby Laboratories Q4 Earnings Call Highlights

Dolby Laboratories reported Q4 earnings with Atmos, Vision, and imaging patents revenue growing 18%, surpassing foundational audio. The company expects mid-single-digit declines in foundational audio and similar growth in other segments for fiscal 2027. New CEO Kevin Whitten focuses on AI and recurring revenue. Dolby anticipates Q1 revenue of $285M-$305M and full-year non-GAAP operating expenses of $775M. The company has $713M in cash and no debt, repurchasing $265M in shares in fiscal 2026.

$DLBMedAI 9/10

Dolby Laboratories Profit Advances In Q4

Dolby Laboratories (DLB) reported Q4 earnings of $80.9M ($0.86 per share), up from $49.3M ($0.51 per share) last year. Adjusted earnings were $117.8M ($1.25 per share). Revenue increased 21.7% to $373.5M. The company guided next quarter's EPS to $0.41-$0.56 and revenue to $285M-$305M.